Genentech Income Statement
View: Annual | Quarterly
| Quarter Ending Jun 08 |
Quarter Ending Mar 08 |
Quarter Ending Dec 07 |
Quarter Ending Sep 07 |
Quarter Ending Jun 07 |
|
|---|---|---|---|---|---|
| Revenue | 3,236.0 | 3,063.0 | 2,969.0 | 2,908.0 | 3,004.0 |
| Cost of Goods Sold | 442.0 | 389.0 | 344.0 | 406.0 | 429.0 |
| Gross Profit | 2,794.0 | 2,674.0 | 2,625.0 | 2,502.0 | 2,575.0 |
| Gross Profit Margin | 86.3% | 87.3% | 88.4% | 86.0% | 85.7% |
| SG&A Expense | 1,419.0 | 1,016.0 | 1,493.0 | 1,311.0 | 1,342.0 |
| Depreciation & Amortization | 146.0 | 139.0 | 147.0 | 130.0 | 109.0 |
| Operating Income | 1,229.0 | 1,519.0 | 985.0 | 1,061.0 | 1,124.0 |
| Operating Margin | 38.0% | 49.6% | 33.2% | 36.5% | 37.4% |
| Nonoperating Income | 92.0 | 74.0 | 40.0 | 84.0 | 75.0 |
| Nonoperating Expenses | 14.0 | 18.0 | 23.0 | 18.0 | 17.0 |
| Income Before Taxes | 1,307.0 | 1,575.0 | 1,002.0 | 1,127.0 | 1,182.0 |
| Income Taxes | 526.0 | 592.0 | 371.0 | 442.0 | 435.0 |
| Net Income After Taxes | 781.0 | 983.0 | 631.0 | 685.0 | 747.0 |
| Continuing Operations | 781.0 | 983.0 | 631.0 | 685.0 | 747.0 |
| Discontinued Operations | -- | -- | -- | -- | -- |
| Total Operations | 781.0 | 983.0 | 631.0 | 685.0 | 747.0 |
| Total Net Income | 781.0 | 983.0 | 631.0 | 685.0 | 747.0 |
| Net Profit Margin | 24.1% | 32.1% | 21.3% | 23.6% | 24.9% |
| Diluted EPS from Total Net Income ($) | 0.73 | 0.92 | 0.59 | 0.64 | 0.70 |
| Dividends per Share | -- | -- | -- | -- | -- |





